Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic indexElwood, J. Mark; Tawfiq, Essa; TinTin, Sandar; Marshall, Roger J.; Phung, Tung M.; Campbell, Ian; Harvey, Vernon; Lawrenson, Ross · BMC Cancer · 2018

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent seriesGreen, Andrew R; Soria, Daniele; Stephen, Jacqueline; Powe, Desmond G; Nolan, Christopher C; Kunkler, Ian; Thomas, Jeremy; Kerr, Gillian R; Jack, Wilma; Cameron, David; Piper, Tammy; Ball, Graham R; Garibaldi, Jonathan M; Rakha, Emad A; Bartlett, John MS; Ellis, Ian O · The Journal of Pathology: Clinical Research · 2016

A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trialKlintman, M.; Nilsson, F.; Bendahl, P.- O.; Ferno, M.; Liljegren, G.; Emdin, S.; Malmstrom, P. · Annals of Oncology · 2013

Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor�2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factorOhara, Masahiro; Matsuura, Kazuo; Akimoto, Etsushi; Noma, Midori; Doi, Mihoko; Nishizaka, Takashi; Kagawa, Naoki; Itamoto, Toshiyuki · Molecular and Clinical Oncology · 2016